
Injective (CRYPTO:INJ) said Layer-1 blockchains will face increasing pressure to compromise on decentralisation as demand for faster transactions and higher throughput grows with broader blockchain adoption.
Injective Chief Executive Officer Eric Chen said the challenge will become more significant as institutional adoption and AI-driven financial applications increase network activity, placing greater demands on blockchain infrastructure.
“In our mind, it’s essentially about finding scaling opportunities without compromising the fundamental pillars that define what a blockchain is,” said Injective Chief Executive Officer Eric Chen.
Chen said centralising network operations through a single validator or server could improve efficiency but would create a single point of failure, while Injective instead aims to improve performance through dedicated scaling zones and Layer-2 solutions.
Chen said balancing scalability, security and decentralisation will remain an ongoing challenge for blockchain developers, and there was no market reaction because the comments did not involve a listed company or token announcement.
The comments reflect the long-standing blockchain trilemma, which holds that decentralisation, security and scalability cannot all be fully optimised at the same time.
According to Chen, increasing scalability too aggressively can weaken decentralisation, making it important for blockchain developers to improve performance without undermining the core principles of distributed networks.
At the time of reporting, Injective price was $4.75.